Silicomicobacteriosis (SM), diagnosis and prognosis, follow up 2,5 years

G. Orlova (St Petersburg, Russian Federation)

Source: International Congress 2017 – Silicosis has not gone away
Session: Silicosis has not gone away
Session type: Oral Presentation
Number: 487
Disease area: Interstitial lung diseases

Congress or journal article abstractWebcastSlide presentationE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
G. Orlova (St Petersburg, Russian Federation). Silicomicobacteriosis (SM), diagnosis and prognosis, follow up 2,5 years. 487

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The efficiency of Langerhans‘ cell hystioctosis treatment (3 years follow-up)
Source: Annual Congress 2011 - Rare diffuse lung diseases
Year: 2011


The evolution of tuberculosis incidence in romanian children (0-14 years) in the last ten years
Source: Eur Respir J 2002; 20: Suppl. 38, 534s
Year: 2002

The analysis of lung cancer patients (LCP) survival during 5 year period after diagnosis of disease
Source: Eur Respir J 2006; 28: Suppl. 50, 88s
Year: 2006

Survival trend of patients with lung cancer (LC) in Cáceres (Spain) (1991-2003). Analysis based on TNM staging, histology, modality-treatment and time-period of diagnosis
Source: Eur Respir J 2007; 30: Suppl. 51, 669s
Year: 2007

The prognosis of childhood asthma, 10 year follow-up
Source: Eur Respir J 2005; 26: Suppl. 49, 452s
Year: 2005

Hypoplasia of lung (frequency, particular features of course, clinic, diagnosis, results of treatment)
Source: Eur Respir J 2007; 30: Suppl. 51, 650s
Year: 2007

The incidence, prevalence and features of the course of pulmonary sarcoidosis (PS) in Saint-Petersburg for 1998-2006 years
Source: Annual Congress 2007 - Epidemiology of various lung diseases
Year: 2007


Advanced pulmonary sarcoidosis: long-term follow-up of 10 years or more.
Source: International Congress 2018 – Sarcoidosis: from basic research to patient outcomes
Year: 2018




Evaluation of two different therapeutic approaches in the management of patients with sarcoidosis: chest x-ray presentation after 12 months prednisone therapy or observation, in 20 years interval (1976-1980 versus 1996-2000)
Source: Eur Respir J 2004; 24: Suppl. 48, 713s
Year: 2004

Are we missing asthma COPD overlap (ACO) diagnosis among patient with COPD?Alameeri Amel(1), Dudina Alexandra(1) , Stephen Lane(1), Kennedy Merian(2)
Source: International Congress 2019 – FeNO in airway diseases and asthma-COPD overlap identification
Year: 2019

When do we extend the treatment of tuberculosis (TB) more than 6 months?
Source: Annual Congress 2007 - Clinical tuberculosis
Year: 2007


Introduction: the difference between men and boys is the size (and price) of their toys
Source: Annual Congress 2005 - Lung cancer staging: not as simple as it seems?
Year: 2005

The adventure of bronchiectasis patients through 13 years: clinical follow-up, microbiology, surgery and mortality
Source: International Congress 2017 – Clinical challenges in chronic lung diseases
Year: 2017


Bone and joint tuberculosis in Bradford: a 6 year review (1999-2004)
Source: Annual Congress 2005 - Management of tuberculosis pulmonary, extrapulmonary peculiarities
Year: 2005


Pulmonary thromboembolism in HIV (+) patients under 50 years old: a six year study
Source: Annual Congress 2007 - Venous thromboembolic disease
Year: 2007


The respiratory manifestations of Behcet disease: a study about 26 cases colligated in 12 years (1995-2007)
Source: Annual Congress 2008 - Rare clinical cases
Year: 2008

Inpatient resource utilisation in younger (2-5 yrs) and older (6-14 yrs) asthmatic children in Finland
Source: Eur Respir J 2002; 20: 397-402
Year: 2002



Community acquired pneumonia (CAP) in children over 3 years old - etiology, antibiotic sensitiveness and treatment
Source: Eur Respir J 2004; 24: Suppl. 48, 714s
Year: 2004

The effectiveness of plasmaferesis in patients with relapsing and progressing course of pulmonary sarcoidosis (5 years follow-up)
Source: Annual Congress 2010 - Clinical issues in diffuse parenchymal lung disease
Year: 2010


Lung function abnormalities in asthmatic children (a 3-5 year follow-up study)
Source: Eur Respir J 2001; 18: Suppl. 33, 120s
Year: 2001